Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: Impact on filter life and azotemic control

被引:73
作者
Uchino, S
Fealy, N
Baldwin, I
Morimatsu, H
Bellomo, R
机构
[1] Austin & Repatriat Med Ctr, Dept Med, Melbourne, Vic 3084, Australia
[2] Austin & Repatriat Med Ctr, Dept Intens Care, Melbourne, Vic 3084, Australia
来源
NEPHRON CLINICAL PRACTICE | 2003年 / 94卷 / 04期
关键词
acute kidney failure; critical illness; renal replacement therapy; hemofiltration; clearance; dilution;
D O I
10.1159/000072492
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: To determine the impact of replacement fluid infusion site on filter life and azotemic control during continuous veno-venous hemofiltration (CVVH). Methods: Pre-dilution CVVH was conducted from February 2001 to December 2001 and then practice was changed to post-dilution (from January 2002 to July 2002). Filter life was prospectively observed and the following data obtained for each filter: starting date and time, ending date and time, heparin use, heparin dose and protamine use. Daily creatinine, urea, INR, APTT and platelet count were also collected. Results: Forty-eight patients were studied (33 in pre-dilution and 15 in post-dilution) for a total of 309 filters (202 in pre-dilution and 107 in post-dilution). The median filter life was significantly shorter in the post-dilution period (18.0 vs. 13.0 h, p=0.021). Multivariate linear regression analysis showed that pre-dilution was a significant independent predictor of increased filter life (p=0.029), together with platelet count (p=0.0035) and heparin dose (p=0.046). There was no significant improvement in daily creatinine and/or urea reduction in the post-dilution period (% Delta creatinine: 7.9 vs. 10.2%/ day, p=0.99, urea: 5.4 vs. 9.7%/day, p=0.78). Conclusions: Post-dilution was associated with reduced filter life without any beneficial effect on daily changes in urea and creatinine levels. Pre-dilution appears a preferable technical approach to CVVH. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:C94 / C98
页数:5
相关论文
共 21 条
[1]   Inability of the activated partial thromboplastin time to predict heparin levels - Time to reassess guidelines for heparin assays [J].
Baker, BA ;
Adelman, MD ;
Smith, PA ;
Osborn, JC .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (21) :2475-2479
[2]   A prospective study of thromboelastography (TEG) and filter life during continuous veno-venous hemofiltration [J].
Baldwin, I ;
Tan, HK ;
Bridge, N ;
Bellomo, R .
RENAL FAILURE, 2000, 22 (03) :297-306
[3]  
DAVENPORT A, 1997, AM J KIDNEY DIS S, V30, P20
[4]  
David S, 1992, Contrib Nephrol, V96, P77
[5]   Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous hemofiltration: A double-blind, randomized, crossover study [J].
de Pont, ACJM ;
Oudemans-van Straaten, HM ;
Roozendaal, KJ ;
Zandstra, DF .
CRITICAL CARE MEDICINE, 2000, 28 (02) :421-425
[6]   Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent [J].
Fiaccadori, E ;
Maggiore, U ;
Rotelli, C ;
Minari, M ;
Melfa, L ;
Cappè, G ;
Cabassi, A .
INTENSIVE CARE MEDICINE, 2002, 28 (05) :586-593
[7]   Citrate anticoagulation in continuous venovenous hemodiafiltration:: a metabolic challenge [J].
Gabutti, L ;
Marone, C ;
Colucci, G ;
Duchini, F ;
Schönholzer, C .
INTENSIVE CARE MEDICINE, 2002, 28 (10) :1419-1425
[8]  
HONORE PM, 1997, CRIT CARE S1, V1, P97
[9]  
Kaplan A A, 1985, Trans Am Soc Artif Intern Organs, V31, P28
[10]   APACHE-II - A SEVERITY OF DISEASE CLASSIFICATION-SYSTEM [J].
KNAUS, WA ;
DRAPER, EA ;
WAGNER, DP ;
ZIMMERMAN, JE .
CRITICAL CARE MEDICINE, 1985, 13 (10) :818-829